ICPH – Inserm UMR S 1174

Publications en 2009


Classées par année :  2012  |  2011  |  2010  |  2009  |  2008  |  2007  |  2006

 

Collado-Hilly, M., and J.F. Coquil. 2009. Ins(1,4,5)P3 receptor type 1 associates with AKAP9 (AKAP450 variant) and protein kinase A type IIbeta in the Golgi apparatus in cerebellar granule cells. Biol Cell. 101:469-80.

 

Delaunay, J.L., A.M. Durand-Schneider, D. Delautier, A. Rada, J. Gautherot, E. Jacquemin, T. Ait-Slimane, and M. Maurice. 2009. A missense mutation in ABCB4 gene involved in progressive familial intrahepatic cholestasis type 3 leads to a folding defect that can be rescued by low temperature. Hepatology. 49:1218-27.

 

Dupont, G., and L. Combettes. 2009. What can we learn from the irregularity of Ca2+ oscillations? Chaos. 19:037112.

 

Gonzales, E., A. Davit-Spraul, C. Baussan, C. Buffet, M. Maurice, and E. Jacquemin. 2009. Liver diseases related to MDR3 (ABCB4) gene deficiency. Front Biosci. 14:4242-56.

 

Gonzales, E., M.F. Gerhardt, M. Fabre, K.D. Setchell, A. Davit-Spraul, I. Vincent, J.E. Heubi, O. Bernard, and E. Jacquemin. 2009. Oral cholic acid for hereditary defects of primary bile acid synthesis: a safe and effective long-term therapy. Gastroenterology. 137:1310-1320 e1-3.

 

Jacquemin, E., B. Hermeziu, Y. Kibleur, I. Friteau, D. Mathieu, F. Le Coz, D. Moyse, M. Gerardin, E. Jacqz-Aigrain, and A. Munck. 2009. Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis. J Clin Pharm Ther. 34:515-22.

 

Commentaires

Laisser un commentaire

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *